欢迎来到 Synaptic Systems中国区代理商/公司/官网
全国咨询热线: 13212737804
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18327026838

传真:18771997407

邮箱:sales@amyjet.com

新闻中心
logo-schwarz.pngexocell.jpg

艾美捷科技代理Peptides.de品牌全系列产品


Peptides.de是一家专注于高质量肽产品生产的的德国企业。公司创立于2001年,总部位于德国赫尼希斯多夫。从单一肽到百万级肽库,从线性链到环状结构,从短肽到超长序列,从粗品到高纯精肽,从修饰化到标记化,从天然氨基酸到非天然变体,Peptides.de提供全维度肽与肽模拟物解决方案,覆盖新抗原筛选、过继性免疫治疗、T细胞刺激实验、表位作图、ELISpot检测、药物发现及芯片技术等核心领域。


Peptides.de公司不仅生产肽,还自主开发用于肽合成的核心设备——肽合成机器人。凭借其专利技术超声肽合成平台 (USPS®),团队能够在短时间高效生产数百种肽,并精准实现客户所需的各种修饰。


Peptides.de.png


▍ReVacc Scientific公司产品

Peptides.de核心业务涵盖:目录肽现货供应、专属肽链定制合成、个性化肽池构建、高通量肽库开发、肽芯片制备服务、功能型修饰肽生产以及精密预分装服务。

产品目录.png


▍Peptides.de部分产品列表

品名货号规格
ADV hexon (HLA-B*35:01)EP07882_11 mg;5 mg
ADV hexon 114 -124 (HLA-B*07:02)EP07881_11 mg;5 mg
ADV hexon 37-45 (HLA-A*24:02)EP07880_11 mg;5 mg
ADV hexon 886-894 (HLA-A*01:01)EP10774_11 mg;5 mg
ADV Hexon 917-925 (HLA-A*02:01)EP07914_11 mg;5 mg
BKV VP1 108-116 (HLA-A*02:01)EP11456_11 mg;5 mg
BRLF1 109-117 (HLA-A*02:01)EP11139_11 mg;5 mg
Chlamydia trachomatis MOMP 258-266 (HLA-A*02:01)EP11114_11 mg;5 mg
EBNA 3a (596-604)EP10789_11 mg;5 mg
EBNA-1 Protein (562-570)EP04510_11 mg;5 mg
EBV BALF-4 276-284 (HLA-A*02:01)EP11237_11 mg;5 mg
EBV BMLF-1 280-288 (HLA-A*02:01)EP07604_11 mg;5 mg
EBV BMRF1 116-128 (HLA-B*07:02)EP11138_11 mg;5 mg
EBV BMRF1 208-216 (HLA-A*02:01)EP11127_11 mg;5 mg
EBV BRLF-1 148-156 (HLA-A*03:01)EP11482_11 mg;5 mg
EBV BRLF1 101-109 (HLA-A*29:02)EP11142_11 mg;5 mg
EBV BRLF1 134-142 (HLA-A*11:01)EP11140_11 mg;5 mg
EBV BRLF1 28-37 (HLA-A*24:02)EP11141_11 mg;5 mg
EBV BZLF-1 190-197 (HLA-B*08:01)EP07899_11 mg;5 mg
EBV BZLF-1 54-64 (HLA-B*35:01)EP11143_11 mg;5 mg
EBV BZLF-1 54-64 mutant (HLA-B*35:01)EP11144_11 mg;5 mg
EBV BZLF1 44-52 (HLA-B*07:02)EP11214_11 mg;5 mg
EBV EBNA 3A 246-253 (HLA-A*24:02)EP11147_11 mg;5 mg
EBV EBNA 3B 399-408 (HLA-A*11:01)EP11150_11 mg;5 mg




" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Peptides.de品牌全系列产品">
艾美捷科技代理Peptides.de品牌全系列产品
...
阅读详情
Anogen.jpg

Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。

 

Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.

 

Anogen的主要产品包括:

Monoclonal Antibodies

Polyclonal Antibodies

Matched Antibody Pairs

ELISA Kits

 

按照研究领域细分:

Inflammatory & Growth Factors

Cell Biology & Molecular Biology

Immunoassay Reagents

Infection & Toxin

Coagulation Factors

Hormone

Neurological Disorder

Tumor Research


品名货号规格
mAb anti-Human TNF-α, CH8810MO-C40003A0.1 mg
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, C2H9MO-C40003D0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, C2A7MO-C40003F0.1 mg
mAb anti-Human TNF-α, C5G7MO-C40003G0.1 mg
mAb anti-Human TNF-α, C4C7MO-C40003H0.1 mg
mAb anti-Human IFN-γ, 315MO-C40004D0.1 mg
mAb anti-Human IFN-γ, 165MO-C40004E0.1 mg
mAb anti-Human IFN-γ, 23MO-C40004F0.1 mg
mAb anti-Human CCR1, 293MO-C40005A0.1 mg
mAb anti-Human TGF-β, TB21MO-C40009A0.1 mg
mAb anti-Human TGF-β, 2C5MO-C40009B0.1 mg
mAb anti-Human TGF-β, 2C6MO-C40009D0.1 mg
mAb anti-Human TGF-β, 2E6MO-C40009E0.1 mg
mAb anti-Human TGF-β, 8C4MO-C40009F0.1 mg
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-61MO-C40017E0.1 mg
mAb anti-Human IL-8, 257MO-C40017F0.1 mg
mAb anti-Human IL-8, 807MO-C40017G0.1 mg
mAb anti-Human MCP-1, S8MO-C40021A0.1 mg
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, 9G10MO-C40021E0.1 mg
mAb anti-Human MCP-1, S382MO-C40021F0.1 mg
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 513MO-C40028D0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 291MO-C40028G0.1 mg
mAb anti-Human SAA, 504MO-C40028H0.1 mg
mAb anti-Human SAA, 585MO-C40028J0.1 mg
mAb anti-Human SAA, 426MO-C40028K0.1 mg
mAb anti-Human SAA, 38MO-C40028L0.1 mg
mAb anti-Human SAA, 132MO-C40028M0.1 mg
mAb anti-Human SAA, S3MO-C40028N0.1 mg
mAb anti-Human IL-1β, S1H12MO-C40029A0.1 mg
mAb anti-Human IL-1β, S1B7MO-C40029B0.1 mg
mAb anti-Human IL-1β, S3F12MO-C40029G0.1 mg
mAb anti-Human IL-1β, 464MO-C40029H0.1 mg
mAb anti-Human IL-2, 5A8,MO-C40032A0.1 mg
mAb anti-Human IL-2, 9F9,MO-C40032B0.1 mg
mAb anti-Human IL-2, 10C4MO-C40032C0.1 mg
mAb anti-Human IL-2, 8C2MO-C40032D0.1 mg
mAb anti-Human IL-2, 6F11MO-C40032E0.1 mg
mAb anti-Human IL-2, 6B1MO-C40032F0.1 mg
mAb anti-Human EGF, S-21MO-C40044A0.1 mg
mAb anti-Human EGF, S-120MO-C40044B0.1 mg
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-145MO-C40044E0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-147MO-C40044G0.1 mg
mAb anti-Human EGF, S-177MO-C40044H0.1 mg
mAb anti-Human G-CSFR, S-1252MO-C40045A0.1 mg
mAb anti-Human G-CSFR, S-1268MO-C40045B0.1 mg
mAb anti-Human G-CSFR, S-1284MO-C40045D0.1 mg
mAb anti-Human G-CSFR, S-1374MO-C40045E0.1 mg
mAb anti-Human G-CSFR, S-425MO-C40045F0.1 mg
mAb anti-Human G-CSFR, S-1390MO-C40045G0.1 mg
mAb anti-Human bFGF, F-343MO-C40046A0.1 mg
mAb anti-Human bFGF, F-74MO-C40046B0.1 mg
mAb anti-Human bFGF, F-474MO-C40046F0.1 mg
mAb anti-Human bFGF, F-3MO-C40046H0.1 mg
mAb anti-Human EPO, 85MO-C40047A0.1 mg
mAb anti-Human M-CSF, 116MO-C40048A0.1 mg
mAb anti-Human M-CSF, 692MO-C40048B0.1 mg
mAb anti-Human M-CSF, 21MO-C40048D0.1 mg
mAb anti-Human MIP-1α, 116MO-C40051A0.1 mg
mAb anti-Human MIP-1α, 125MO-C40051D0.1 mg
mAb anti-Human MIP-1α, 548MO-C40051F0.1 mg
mAb anti-Human MIP-1α, 199MO-C40051G0.1 mg
mAb anti-Human MIP-1α, 400MO-C40051L0.1 mg
mAb anti-Human MIP-1α, 103MO-C40051M0.1 mg
mAb anti-Human MIP-1α, 376MO-C40051N0.1 mg
mAb anti-Human MIP-1α, 426MO-C40051P0.1 mg
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 343MO-C40088B0.1 mg
mAb anti-Human MCP-3, 490MO-C40088D0.1 mg
mAb anti-Human MCP-3, 768MO-C40088E0.1 mg
mAb anti-Human MCP-3, 1057MO-C40088F0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 1015MO-C40088H0.1 mg
mAb anti-Human IL-16, 59MO-C40089G0.1 mg
mAb anti-Human IL-16, 210MO-C40089H0.1 mg
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 568MO-C40089M0.1 mg
mAb anti-Human IL-16, 572MO-C40089N0.1 mg
mAb anti-Human GM-CSF, 29MO-C40090A0.1 mg
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 204MO-C40090E0.1 mg
mAb anti-Human GM-CSF, 489MO-C40090F0.1 mg
mAb anti-Human GM-CSF, 120MO-C40090G0.1 mg
mAb anti-Human GM-CSF, 26MO-C40090H0.1 mg
mAb anti-Human GM-CSF, 174MO-C40090K0.1 mg
mAb anti-Human GM-CSF, S333MO-C40090L0.1 mg
mAb anti-Human IL-6, 2E10MO-C40091B0.1 mg
mAb anti-Human IL-6, 8E10MO-C40091C0.1 mg
mAb anti-Human IL-6, 5G8MO-C40091D0.1 mg
mAb anti-Human IL-6, 1B6MO-C40091E0.1 mg
mAb anti-Human IL-6, 1E3MO-C40091F0.1 mg
mAb anti-Human IL-6, 6D7MO-C40091G0.1 mg
mAb anti-Human IL-6, 9D8MO-C40091H0.1 mg
mAb anti-Human IL-10, 4H2MO-C40092A0.1 mg
mAb anti-Human IL-10, 6D2MO-C40092B0.1 mg
mAb anti Human IL-17A clone 4C1, CaptureMO-C40093A0.1mg
mAb anti Human IL-17A clone 2F3MO-C40093B0.1mg
mAb anti Human IL-17A clone 8H7MO-C40093C0.1mg
mAb anti Human IL-17A clone 5B4MO-C40093D0.1mg
mAb anti Human IL-17A clone 1E2MO-C40093E0.1mg
mAb anti Human IL-17A clone 2D11MO-C40093H0.1mg
mAb anti Human IL-17A clone 3C1MO-C40093I0.1mg
mAb anti Human IL-17A clone 3H11, DetectorMO-C40093K0.1mg
mAb anti Human IL-17A clone 5A9MO-C40093M0.1mg
mAb anti Human IL-17A clone 6F12MO-C40093O0.1mg
mAb anti Human IL-17A clone 7F10MO-C40093S0.1mg
mAb anti Human IL-17A clone 10F9MO-C40093W0.1mg
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti-human LIF, Clone 2C6MO-C40096A0.1mg
mAb anti-human LIF, Clone 3F4MO-C40096B0.1mg
mAb anti-human LIF, Clone 8B10MO-C40096C0.1mg
mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4MO-H40001B0.1 mg
mAb anti-GAPDH, H8MO-H40002A0.1 mg
mAb anti-HA Tag, HA52MO-H40004A0.1 mg
mAb anti-His Tag, 10A12MO-H40005B0.1 mg
mAb anti-Myc Tag, MycA7MO-H40006A0.1 mg
mAb anti-V5 Tag, V531MO-H40007A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 163MO-I40002C0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mgMO-I40002E0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 425MO-I40002I0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 1027MO-I40002J0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 287MO-I40002N0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 161MO-I40002P0.1 mg
mAb anti-HBsAg, RM-1MO-I40013A0.1 mg
mAb anti-HCV Core Protein, A1/3D1MO-I40015A0.1 mg
mAb anti-HCV Core Protein, B2MO-I40015B0.1 mg
mAb anti-HCV Core Protein, C3MO-I40015E0.1 mg
mAb anti-HCV NS-4, 7B7/5G9MO-I40016B0.1 mg
mAb anti-HCV NS-4, 5D4/10E7MO-I40016D0.1 mg
mAb anti-HCV NS-4, 7E11MO-I40016F0.1 mg
mAb anti-HCV NS-4, 202MO-I40016J0.1 mg
mAb anti-HCV NS-4, 101MO-I40016K0.1 mg
mAb anti-HCV NS-4, 174MO-I40016L0.1 mg
mAb anti-HCV NS-4, 497MO-I40016M0.1 mg
mAb anti-HCV NS-3, 70-13MO-I40018A0.1 mg
mAb anti-HCV NS-3, 1-5MO-I40018B0.1 mg
mAb anti-HCV NS-3, 12-15MO-I40018D0.1 mg
mAb anti-HCV NS-3, 5-11MO-I40018E0.1 mg
mAb anti-HCV NS-3, 24-8MO-I40018F0.1 mg
mAb anti-HCV NS-3, 20-8MO-I40018G0.1 mg
mAb anti-HCV NS-3, 113MO-I40018H0.1 mg
mAb anti-HCV NS-3, 281MO-I40018J0.1 mg
mAb anti-HCV NS-3, 806MO-I40018K0.1 mg
mAb anti-HCV NS-3, 5MO-I40018L0.1 mg
mAb anti-HCV NS-3, 328MO-I40018M0.1 mg
mAb anti-HCV NS-3, 251MO-I40018N0.1 mg
mAb anti-HCV NS-3, 242MO-I40018P0.1 mg
mAb anti-HCV NS-3, 133MO-I40018Q0.1 mg
mAb anti-HEV, S-13MO-I40019B0.1 mg
mAb anti-HEV, 4H5MO-I40019C0.1 mg
mAb anti-HEV, 2H6MO-I40019D0.1 mg
mAb anti-HEV, 2H2MO-I40019E0.1 mg
mAb anti-HEV, 1B6MO-I40019F0.1 mg
mAb anti-HEV, 5H4MO-I40019G0.1 mg
mAb anti-HP CagA, 10E9,MO-I40020A0.1 mg
mAb anti-HP CagA, 5H10MO-I40020B0.1 mg
mAb anti-HP CagA, 5C6MO-I40020C0.1 mg
mAb anti-HP CagA, 3C10,MO-I40020D0.1 mg
mAb anti-HP CagA, 3C1MO-I40020E0.1 mg
mAb anti-TB 38KD Antigen, D2G2MO-I40021A0.1 mg
mAb anti-TB 38KD Antigen, C12H11MO-I40021B0.1 mg
mAb anti-TB 38KD Antigen, C11B10MO-I40021C0.1 mg
mAb anti-TB 38KD Antigen, B12F8MO-I40021D0.1 mg
mAb anti-TB 38KD Antigen, A11D2MO-I40021E0.1 mg
mAb anti-TB 38KD Antigen, A2H8MO-I40021F0.1 mg
mAb anti-Human CD3, JXT3MO-L40001A0.1 mg
Rat anti-Mouse CD4, JXYT4MO-L400260.1 mg
Rat anti-Mouse CD8, JXYT8MO-L400270.1 mg
mAb anti-Human CD11α, A11MO-L400280.1 mg
mAb anti-Human HLA-ABC, LY5.1MO-L400330.1 mg
mAb anti-Human CD71 Transferrin Receptor, CY-TFRMO-L400420.1 mg
mAb anti-Human PD-1 / CD279, 1C4MO-L40043A0.1 mg
mAb anti-Human PD-1 / CD279, 7C9, CaptureMO-L40043B0.1 mg
mAb anti-Human PD-1 / CD279, 9E11MO-L40043E0.1 mg
mAb anti-Human PD-1 / CD279, 9B4MO-L40043F0.1 mg
mAb anti-Human PD-1 / CD279, B1C4MO-L40043G0.1 mg
mAb anti-Human PD-1 / CD279, 7G12, DetectorMO-L40043L0.1 mg
mAb anti-Human PD-1 / CD279, 2H7MO-L40043M0.1 mg
mAb anti Human PD-L1, clone 6A5MO-L40044E0.1 mg
mAb anti Human PD-L1 clone 8C12MO-L40044F0.1 mg
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 11D11MO-L40044M0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti Human PD-L1 clone 12D9MO-L40044O0.1 mg
mAb anti Human PD-L1 clone 15F2MO-L40044R0.1 mg
mAb anti Human PD-L1, clone 10B12MO-L40044S0.1 mg
mAb anti Human CD47, clone 1G10MO-L40045A0.1 mg
mAb anti Human CD47, clone 8H7MO-L40045B0.1 mg
mAb anti Human CD47, clone 9F10MO-L40045C0.1 mg
mAb anti Human CD44, clone 2G7MO-L40046A0.1 mg
mAb anti Human CD44, clone 3C7MO-L40046B0.1 mg
mAb anti-hCG-α, CH5MO-M40010A0.1 mg
mAb anti-hCG-α, CH7MO-M40010B0.1 mg
mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mgMO-M40011A0.1 mg
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-Human Ig Kappa Light Chain, YCK1MO-M400200.1 mg
mAb anti-Human B2MG, D6E4MO-M40021B0.1 mg
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D6D1MO-M40021D0.1 mg
mAb anti-Human B2MG, D2A10MO-M40021E0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human CRP, 67A1MO-M40023B0.1 mg
mAb anti-human CRP, N1G1MO-M40023D0.1 mg
mAb anti-human CRP, S5G1MO-M40023E0.1 mg
mAb Rat anti-Aflatoxin, 1C6, 0.1 mgMO-M40025A0.1 mg
mAb Rat anti-Aflatoxin, 1E6, 0.1 mgMO-M40025B0.1 mg
mAb Rat anti-Aflatoxin, 2E4MO-M40025D0.1 mg
mAb anti-Human Albumin, S4D6MO-M400360.1 mg
mAb anti-Human Factor IX, F9-1, .01 mgMO-M400370.1 mg
mAb anti-Human Protein C, HLW-C, 0.1 mgMO-M400380.1 mg
mAb anti-Human Factor X, F10-1, 0.1 mgMO-M400390.1 mg
mAb anti-Human GP IIb/IIIa, 237, 0.1 mgMO-M40040A0.1 mg
mAb anti-Human GP IIb/IIIa, 474, 0.1 mgMO-M40040B0.1 mg
mAb anti-Human GP IIb/IIIa, Y8MO-M40040D0.1 mg
mAb anti-Human GP IIb/IIIa, 700MO-M40040E0.1 mg
mAb anti-Human GP IIb/IIIa, 585MO-M40040F0.1 mg
mAb anti-Human GP IIb/IIIa, 8MO-M40040H0.1 mg
mAb anti-Human GP IIb/IIIa, 291MO-M40040J0.1 mg
mAb anti-Human GP IIb/IIIa, 262MO-M40040N0.1 mg
mAb anti-Human GP IIb/IIIa, 71MO-M40040Q0.1 mg
mAb anti-Human GP IIb/IIIa, 128MO-M40040S0.1 mg
mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mgMO-M400410.1 mg
mAb anti-Human PTP1-C, PTY6MO-M40043A0.1 mg
mAb anti-Human PTP1-C, PTY11MO-M40043B0.1 mg
mAb anti-Human PTP1-C, PTY15MO-M40043D0.1 mg
mAb anti-Human PTP1-C, PTY10MO-M40043E0.1 mg
mAb anti-Human PTP1-C, PTY13MO-M40043F0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human Raf-1, 410MO-M40091E0.5 mg
mAb anti-Human Raf-1, 540MO-M40091G0.5 mg
mAb anti-Human Raf-1, 863MO-M40091J0.5 mg
mAb anti-Human Raf-1, 163MO-M40091M0.5 mg
mAb anti-Human NSE, 145MO-M40092A0.5 mg
mAb anti-Human NSE, 1G6MO-M40092B0.5 mg
mAb anti-Human NSE, 171MO-M40092C0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3B3MO-M40093A0.1 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3F8MO-M40093D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 3F5MO-M40094A0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1H3MO-M40094B0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 6C8MO-M40094C0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4A2MO-M40094E0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7H7MO-M40094F0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5A4MO-M40094G0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4B7MO-M40094H0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7G10MO-M40094I0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1F10MO-M40094J0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 8B2MO-M40095B0.1 mg
mAb anti-Amyloid β Peptide 40, 4B1MO-M40095C0.1 mg
mAb anti-Human α1-antitrypsin, 5G5MO-M40096A0.1 mg
mAb anti-Human α1-antitrypsin, 9F2MO-M40096B0.1 mg
mAb anti-Human α-Synuclein, 4H11MO-M40097A0.1 mg
mAb anti-Human α-Synuclein, 4C1MO-M40097B0.1 mg
mAb anti-Human α-Synuclein, 4B4MO-M40097C0.1 mg
mAb anti-Human α-Synuclein, 8F12MO-M40097D0.1 mg
mAb anti-Human α-Synuclein, 9A9MO-M40097E0.1 mg
mAb anti-Human α1-antichymotrypsin, 3E11MO-M40098A0.1 mg
mAb anti-Human α1-antichymotrypsin, B2B3MO-M40098B0.1 mg
mAb anti-Human α1-antichymotrypsin, B4H12MO-M40098C0.1 mg
mAb anti-Human α1-antichymotrypsin, B5B11MO-M40098D0.1 mg
mAb anti-Human α1-antichymotrypsin, B7B10MO-M40098E0.1 mg
mAb anti-Human α1-antichymotrypsin, B7H2MO-M40098F0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 1A4MO-M40099A0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 7G9MO-M40099B0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 9B4MO-M40099C0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 2A4MO-M40099D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1MO-M40100A0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8MO-M40100B0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1MO-M40100C0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12MO-M40100D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1MO-M40100E0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11MO-M40100F0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11MO-M40100G0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9MO-M40100H0.1 mg
mAb anti-LCRMP4, 5H5MO-M40101A/
mAb anti-LCRMP4, 2H7MO-M40101B/
mAb anti-LCRMP4 , 7E1MO-M40101C/
mAb anti-Human Phospho-STAT5b [p-Y699], A4B9MO-P40001A0.1 mg
mAb anti-Human Phospho-STAT5b [p-Y699], A2H6MO-P40001B0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], B4A12MO-P40002A0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], D7H2MO-P40002B0.1 mg
mAb anti-Human Phospho-CREB [p-S133], A3A4MO-P40003A0.1 mg
mAb anti-Human Phospho-CREB [p-S133], B1C4MO-P40003B0.1 mg
mAb anti-Human FPRL-1 C-terminal, C4F9MO-P40006A0.1 mg
mAb anti-Human FPRL-1 C-terminal, B4D9B10MO-P40006B0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, 3D7MO-P40007A0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, B7H10MO-P40007B0.1 mg
mAb anti-Human Lung Carcinoma, CHALU2MO-T40005B0.1 mg
mAb anti-Human Lung Carcinoma, 3504MO-T40005C0.1 mg
mAb anti-Human Hepatocellular Carcinoma, CHALV1MO-T40006A0.1 mg
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human BPH, YBPH-1MO-T40008A0.1 mg
mAb anti-Human BPH, YBPH-2MO-T40008B0.1 mg
mAb anti-Human PML, B3E9MO-T40010A0.1 mg
mAb anti-Human PML, B4C8MO-T40010B0.1 mg
mAb anti-CA 125, 110MO-T40012A0.1 mg
mAb anti-CA 125, 76MO-T40012B0.1 mg
mAb anti-CA 125, 23MO-T40012C0.1 mg
mAb anti-CA 125, 15MO-T40012D0.1 mg
mAb anti-CA 125MO-T40012E0.1 mg
mAb anti-CA50, 93MO-T40014A0.1 mg
mAb anti-CA50, 826MO-T40014B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available)MO-T40015A0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available)MO-T40015B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available)MO-T40015C0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available)MO-T40015D0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available)MO-T40015E0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available)MO-T40015F0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available)MO-T40015G0.1 mg
mAb anti-Human Colorectal Carcinoma, Y94MO-T400220.1 mg
mAb anti-Human Colorectal Carcinoma/CD3, BS-1MO-T400350.1 mg
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PMA, YPMA-1MO-T40083A0.1 mg
mAb anti-Human PMA, YPMA-2MO-T40083B0.1 mg
mAb anti-Human PSP, YPSP-1MO-T40085A0.1 mg
mAb anti-Human PSP, YPSP-2MO-T40085B0.1 mg
mAb anti-Human PSP, YPSP-3MO-T40085C0.1 mg
mAb anti-Human PSP, YPSP-4MO-T40085D0.1 mg
mAb anti-Human PSMA, YPSMA-1MO-T40086A0.1 mg
mAb anti-Human PSMA, YPSMA-2MO-T40086B0.1 mg
mAb anti-Human PSMA, 4H11MO-T40086C0.1 mg
mAb anti-Human PSMA, 7F3MO-T40086D0.1 mg
mAb anti-Human PTMA, 8H12MO-T40087A0.1 mg
mAb anti-Human PTMA, 9A10MO-T40087B0.1 mg
mAb anti-Human PTMA, 6A3MO-T40087C0.1 mg
mAb anti-Human PTMA, 4G2MO-T40087D0.1 mg
mAb anti-Human PTMA, 5A10MO-T40087E0.1 mg
mAb anti-Human PTMA, 6H7MO-T40087F0.1 mg
mAb anti-Human PTMA, 1F2, CaptureMO-T40087G0.1 mg
mAb anti-Human PTMA, 4C3MO-T40087H0.1 mg
mAb anti-Human PTMA, 4A7, DetectorMO-T40087I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9A4MO-T40088A0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E6MO-T40088B0.1 mg
mAb anti-Human S100A7 (psoriasin), 1A10MO-T40088C0.1 mg
mAb anti-Human S100A7 (psoriasin), 5C2MO-T40088D0.1 mg
mAb anti-Human S100A7 (psoriasin), 10H9MO-T40088E0.1 mg
mAb anti-Human S100A7 (psoriasin), 2A3MO-T40088F0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E5MO-T40088G0.1 mg
mAb anti-Human S100A7 (psoriasin), 5H12MO-T40088H0.1 mg
mAb anti-Human S100A7 (psoriasin), 9C7MO-T40088I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9D5MO-T40088J0.1 mg
mAb anti-Human S100A7 (psoriasin), 3E7MO-T40088K0.1 mg
Human PSA ELISA KitEL1000596 wells
Human IL-8 ELISA KitEL1000896 wells
Human MCAF / MCP-1 ELISA KitEL1000996 wells
Human EGF ELISA KitEL1001096 wells
Human LH ELISA KitEL1001196 wells
Human TSH ELISA KitEL1001296 wells
Neonatal TSH ELISA KitEL10012N96 wells
Ultra-Sensitive Human TSH ELISA KitEL10012U96 wells
Human FSH ELISA KitEL1001396 wells
Human Prolactin ELISA KitEL1001496 wells
Human SAA ELISA KitEL1001596 wells
Human SAA ELISA Kit (2nd Generation)EL10015L96 wells
Human MCP-3 ELISA KitEL1001696 wells
Human TNF-α ELISA KitEL1001996 wells
Human GM-CSF ELISA KitEL1002096 wells
Human IL-16 ELISA KitEL1002196 wells
High Sensitivity Human CRP ELISA KitEL10022hs96 wells
Human IL-6 ELISA KitEL1002396 wells
Human IFN-γ ELISA KitEL1002496 wells
Human IL-2 ELISA KitEL1002596 wells
Human IL-4 ELISA KitEL1002696 wells
Human IL-10 ELISA KitEL1002796 wells
Human IL-1β ELISA KitEL1002896 wells
Human TGF-β1 ELISA KitEL1002996 wells
Human Growth Hormone (hGH) ELISA Kit/Hormone ElisaEL1003096 wells
High Sensitivity Human Growth Hormone (H-hGH) ELISA KitEL10030H96 wells
Human Chorionic Gonadotropin (hCG) ELISA KitEL1003196 wells
Human IL-12 (P70) ELISA KitEL1003296 wells
Human IL-2 sRα ELISA KitEL1003396 wells
Human IL-6 sR ELISA KitEL1003496 wells
Human IL-5 ELISA KitEL1003596 wells
HAMA ELISA KitEL1003696 wells
Human IL-13 Rα2 ELISA KitEL1003996 wells
Human IL-1α ELISA KitEL1004096 wells
Human IL-7 ELISA KitEL1004196 wells
Human IL-11 ELISA KitEL1004296 wells
Human IL-15 ELISA KitEL1004496 wells
Human M-CSF ELISA KitEL1004696 wells
Human TNF-β ELISA KitEL1004796 wells
Human bFGF ELISA KitEL1004896 wells
Human Alphafetoprotein (AFP) ELISA KitEL1004996 wells
Human B2MG ELISA KitEL1005196 wells
Human Carcinoembryonic Antigen (CEA) ELISA KitEL1005296 wells
Human IL-17A ELISA KitEL1005396 wells
Human IL-13 ELISA KitEL1005496 wells
Human IL-22 ELISA KitEL1005596 wells
Human IL-9 ELISA KitEL1005696 wells
Human Amyloid Beta Peptide 42 ELISA KitEL1005796 wells
Human Programmed Death-Ligand 1 (PD-L1) ELISA KitEL1005896 wells
Human Programmed Death-1 (PD-1) ELISA KitEL1005996 wells
Human IL-18 ELISA KitEL1006096 wells
Multiplex Human Cytokine ELISA Kit (Inflammatory)EM1000196 wells
Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines)EM1000296 wells
Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17)EM1000396 wells
Mouse IL-17A ELISA KitMEC100196 wells
Mouse IFN-γ ELISA KitMEC100296 wells
Mouse TNF-α ELISA KitMEC100396 wells
Mouse GM-CSF ELISA KitMEC100496 wells
Mouse MCP-1 ELISA KitMEC100596 wells
Mouse IL-2 ELISA KitMEC100696 wells
Mouse IL-5 ELISA KitMEC100796 wells
Mouse IL-6 ELISA KitMEC100896 wells
Mouse IL-4 ELISA KitMEC100996 wells
Mouse IL-1β ELISA KitMEC101096 wells
Mouse IL-1α ELISA KitMEC101196 wells
Mouse TGF-β1 ELISA KitMEC101296 wells
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled)MO-C40003T0.2 mL
mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled)MO-C40003TB0.1 mL
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled)MO-C40017T0.2 mL
mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled)MO-C40017TB0.1 mL
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, S101, Tracer (HRP Labeled)MO-C40021T0.2 mL
mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled)MO-C40021TB0.1 mL
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mLMO-C40028T0.2 mL
mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mLMO-C40028TB0.1 mL
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-146, Tracer (HRP Labeled)MO-C40044T0.2 mL
mAb anti-Human EGF, S-146, Tracer (Biotin Labeled)MO-C40044TB0.1 mL
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 113, Tracer (HRP Labeled)MO-C40088T0.2 mL
mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled)MO-C40088TB0.1 mL
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 323, Tracer (HRP Labeled)MO-C40089T0.2 mL
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled)MO-C40090T0.2 mL
mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled)MO-C40090TB0.1 mL
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled)MO-C40095TB0.1 mL
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mLMO-I40002T20.2 mL
mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled)MO-L40043TB0.1 mL
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled)MO-L40044TB0.1 mL
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mLMO-M40012T0.2 mL
mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mLMO-M40012TB0.1 mL
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mLMO-M40021T0.2 mL
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mLMO-M40046T0.2 mL
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mLMO-M40047T0.2 mL
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mLMO-M40048T0.2 mL
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mLMO-M40049T0.2 mL
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled)MO-M40050T0.2 mL
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin)MO-M40093TB0.1 mL
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin)MO-M40095TB0.1 mL
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mLMO-T40007T0.2 mL
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mLMO-T40051T0.2 mL
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mLMO-T40052T0.2 mL
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mLMO-T40081T0.2 mL
Human Chorionic Gonadotrophin (hCG), 10 mgAP3000210 mg
Human Immunoglobulin G (IgG), 10 mgIG3000110 mg
Mouse Immunoglobulin G (IgG), 10 mgIG4100210 mg
Mouse Immunoglobulin G2b (IgG2b), 10 mgIG4100410 mg
Rat Immunoglobulin G (IgG)IG4200310 mg
Human Umbilical Cord Serum, 10 mLS3001010 mL
ELISA Coating (EC) Stabilizer, 500 mLS7001500 mL
Human IL-8 Matched Antibody Pair for ELISpotSL10008A5 × 96 wells
Human IL-8 Development Set for ELISpotSL10008B5 × 96 wells
Human IL-8 ELISpot KitSL10008E6 X 96 wells
Human MCAF (MCP-1) Matched Antibody Pair for ELISpotSL10009A5 × 96 wells
Human MCAF (MCP-1) Development Set for ELISpotSL10009B5 × 96 wells
Human MCAF (MCP-1) ELISpot KitSL10009E6 X 96 wells
Human GM-CSF Matched Antibody Pair for ELISpotSL10020A5 × 96 wells
Human GM-CSF Development Set for ELISpotSL10020B5 × 96 wells
Human GM-CSF ELISpot KitSL10020E6 X 96 wells
Human IFN-γ Matched Antibody Pair for ELISpotSL10024A5 × 96 wells
Human IFN-γ Development Set for ELISpotSL10024B5 × 96 wells
Human IFN-γ ELISpot KitSL10024E6 X 96 wells
Human IL-12 (P70) ELISpot KitSL10032E6 X 96 wells
TMB Solution (500 mL Part A & 500 mL Part B)SU60061.0 L
pAb Rabbit anti-HCV Virus, 1.0 mgAI20006P1.0 mg
pAb Rabbit anti-HIV-1 p24, 1.0 mgAI20008P1.0 mg
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
pAb Rabbit anti-Mouse IgG , 1.0 mgAI500051.0 mg
pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mLAI50005P1.0 mL
pAb Rabbit anti-hGH,AI50006P1.0 mg
pAb Chicken anti-human IL-8 (IgY fraction)AI600011.0 mg
pAb Rabbit anti-Human FPRL-1 2nd Extracellular LoopAI70001A0.1 mg
pAb Rabbit anti-Human FPRL-1 C-terminalAI70001B0.1 mg
pAb Rabbit anti-Human PML [Ring Finger Domain]AI70002A0.1 mg
pAb Rabbit anti-Human PML [B-box 1 domain]AI70002B0.1 mg
pAb Rabbit anti-Bcl-2AI70003A0.1 mg
pAb Rabbit anti-Phospho-Bcl-2 (Thr56)AI70003B0.1 mg
pAb Rabbit anti-Phospho-Bcl-xL (Thr115)AI70003D0.1 mg
pAb Rabbit anti-Phospho c-kit (Tyr719)AI70004A0.1 mg
pAb Rabbit anti-Phospho IKK-γ (Ser31)AI70005A0.1 mg
pAb Rabbit anti-NF-κB-p65 (RelA)AI70006A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276)AI70007A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468)AI70008A0.1 mg
pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337)AI70009A0.1 mg
pAb Rabbit anti-Human Serum Albumin (HSA)AI800010.1 mg
pAb Rabbit anti-Human Fibrinogen, 0.1 mgAI800020.1 mg
pAb Rabbit anti-Human TransferrinAI800030.1 mg
pAb Rabbit anti-Human IgA, 0.5 mgAI800040.5 mg
pAb Rabbit anti-human IgM, 0.5 mgAI800050.5 mg
pAb Rabbit anti-Human TREK-1 (K2p2.1)AI80006A0.1 mg
pAb Rabbit anti-Mouse Kchip1AI800070.1 mg
pAb Rabbit anti-Mouse Kchip4AI800080.1 mg
pAb Rabbit anti-Mouse Kv4.3AI80010A0.1 mg
pAb Rabbit anti-Mouse TRPV1AI80011A0.1 mg
pAb Rabbit anti-Mouse TRPV3AI80012A0.1 mg
pAb Rabbit anti-Human JAK2AI80013A0.1 mg
pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mgAI800140.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 42AI900010.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 43AI900020.1 mg


" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Anogen">
Anogen
...
阅读详情
Athern Research & Technology.jpg

艾美捷科技特约代理Athens Research & Technology产品。


Athens Research & Technology公司位于美国乔治亚州雅典市,从1986年以来一直致力于纯化高纯度,高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白等。

 

Athens Research & Technology Inc. has been purifying human proteins and developing polyclonal antisera to those proteins since 1986. We specialize in highly pure, highly active human proteins. We routinely purify serine proteases, protease inhibitors, neutrophil enzymes, apolipoproteins, lipoproteins, platelet proteins, transferrins, immunoglobulins, and more. Researchers around the world have been purchasing these research reagents from us for more than twenty-five years. You'll see our products referenced in major scientific publications in studies of inflammation, coronary disease, autoimmune disease, cancer, Alzheimer's Disease, and so on.

 

Athens Research & Technology公司的主要产品包括:

Coagulation Factors

Enzymes & Inhibitors

Immunoglobulins

Lipoproteins & Apolipoproteins

Low Endotoxin Level Proteins

Milk & Platelet Proteins

Neutrophil Proteins

Transferrins & Apotransferrins

Transport/Other Proteins

All Human Proteins

All Animal Proteins

Antibodies

Assay Kits

" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Athens Research & Technology">
Athens Research & Technology
...
阅读详情
Plant Cell Technology.jpg

美国Plant Cell Technology公司为商业及研究用植物组织培养实验室和植物种植者开发、生产了旗舰产品PPM™ (Plant Preservative Mixture),它是一种广谱抗微生物剂,可以杀死细菌和真菌细胞,防止真菌孢子的萌发,并在较高浓度下能消除内源性污染的外植体。研究表明PPM™活性成分可以渗透过真菌或细菌细胞壁,抑制柠檬酸循环和电子传递链等中心代谢循环中的关键酶的活性,并且可以抑制培养基中的单糖和氨基酸向真菌和细菌细胞的运输。PPM™能有效地抑制植物细胞和植物组织培养中的通过空气、水、人传播的微生物污染及内源性污染,而不会影响体外种子发芽、愈伤组织增殖和愈伤组织的再生。并且,PPM™具有热稳定性,可以和培养基一起灭菌,同时比常用抗生素价更低廉,可以作为植物组织培养基的标准成分。

 

The principal PCT scientist involved in the development of the PPM™ application is Dr. Assaf Guri. Dr. Assaf Guri holds degrees in genetics, applied genetics and plant breeding from the Hebrew University in Jerusalem and Michigan State University in the US. Before joining Plant Cell Technology, Inc., Dr. Guri worked with the Volcani Agricultural Research Center in Israel, Michigan State University in East Lansing, Michigan and DNAP in New Jersey.

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Plant Cell Technology">
Plant Cell Technology
...
阅读详情
BioVision.jpg

BioVision公司是世界顶尖的细胞凋亡和信号传导产品生产商,产品包括检测试剂盒,抗体及重组蛋白,涵盖了细胞凋亡、细胞信号传导和细胞因子研究的各个方面。凋亡产品包括Annexin V 试剂盒、半胱天冬氨酸蛋白酶(Caspases)试剂盒及底物和抑制剂、线粒体膜电位试剂盒、梯状DNA 电泳和TUNEL 试剂盒、凋亡诱导剂、凋亡相关抗体和化学品、细胞增殖检测试剂盒等。

 

BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.

 

BioVision公司的主要产品包括:

Antibodies & Supporting Tools

Biochemicals

Cytokines & Growth Factors

ELISA Kits

Enzyme Inhibitors

EZSolution™ Ready-to-Use Products

Fluorescent Proteins

Laboratory accessories

Metabolism Assay Kits

Molecular Biology

Protein A,G,L & Affinity Conjugates

Proteins & Enzymes

Protein Extraction & Purification

Signaling Pathways

按研究领域细分

Apoptosis

Autophagy

Cardiovascular

Cancer

Cell Damage & Oxidative Stress

Cell Proliferation, Viability & Cytotoxicity

Diabetes, Obesity & Metabolic Syndrome

Drug Metabolism & Disposition

Epigenetics

Exosomes

Infectious Diseases

Metabolism

Neuroscience

Proteostasis

Signal Transduction

" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioVision">
BioVision
...
阅读详情
Chiralix.jpg

艾美捷科技特约代理Chiralix公司产品。

Chiralix是一家专业从事手性有机分子合成和供应的公司,致力于制药公司及生命科学研究领域的实验室研究用特有手性分子的生产和研发。Chiralix集先进的有机分子合成、过渡金属催化、生物催化技术于一身,具备灵活与高效的多种手性分子合成工艺,如基团的氨基酸,叠氮酸,氨基醇及多种肽段模块。除了提供大量的手性分子成品,还提供优质的研发服务,如复杂有机分子的合成等。

 

Chiralix is a specialist in chiral organic synthesis. We offer a unique range of chiral drug-like building blocks on research-scale, aimed at research laboratories in pharmaceutical companies and all others involved in the Life Sciences industry. The integration of our capabilities in the areas of advanced organic synthesis, transition metal catalysis and biocatalysis, enables us to develop flexible and efficient synthetic routes to diversely substituted chiral molecules, such as specialty amino acids, azido acids, amino alcohols and peptide building blocks. In addition to our catalog of unique building blocks, we provide high quality contract research services for our clients in support of their own research efforts. Our services include the custom synthesis of complex organic molecules and the parallel synthesis of compound libraries.

 

Chiralix公司的主要服务包括:

Custom synthesis

Parallel synthesis of focused client-directed compound libraries

Route scouting

Disease state human plasma


" data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Chiralix公司产品">
艾美捷科技特约代理Chiralix公司产品
...
阅读详情
艾美捷官网上传2.5:1.jpgexocell.jpg

艾美捷科技代理Rigaku Reagents品牌。

Rigaku Reagents 是 Rigaku 集团旗下的一家子公司,专注于为X射线晶体学领域提供高质量的化学试剂和工具。Rigaku 集团是全球知名的科学仪器制造商,尤其在X射线分析技术领域具有领先地位。Rigaku Reagents 的主要目标是支持科学家在蛋白质晶体学、材料科学和其他相关领域的研究,提供用于晶体生长、样品制备和分析的高质量试剂和耗材。热门产品包括:Wizard Classic/Wizard Cryo 系列蛋白结晶筛选试剂盒,结晶板,结晶工具,和 PEG3350、PEG6000、PEG8000 等试剂。主要产品类别为:

(1)晶体生长试剂:Rigaku Reagents 提供多种用于蛋白质和小分子晶体生长的试剂,包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。这些试剂经过严格的质量控制,确保实验的可重复性和可靠性。

(2)结晶筛选试剂盒:公司提供多种结晶筛选试剂盒,如 Crystal Screen、Index Screen 和 SaltRx Screen,适用于不同类型的晶体生长实验。这些试剂盒设计科学,能够显著提高晶体生长的成功率。

(3)蛋白质结晶工具:提供用于蛋白质结晶的耗材和设备,如结晶板、密封膜和样品支架。这些工具与 Rigaku 的X射线衍射仪兼容,支持从晶体生长到数据分析的全流程。

(4)小分子结晶试剂:为小分子晶体学研究提供高质量的试剂和工具,支持药物开发、材料科学等领域的研究。

<<< " data-original="http://synaptic.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Rigaku Reagents品牌">
艾美捷科技代理Rigaku Reagents品牌
...
阅读详情

Copyright © 2026 Powered by Synaptic Systems中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap